Workflow
Kenmare Resources plc (KMRPF) Presents at Proactive One2One Investor Forum - Slideshow (OTCMKTS:KMRPF) 2026-05-13
Seeking Alpha· 2026-05-14 07:33
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...
SmartCentres Real Estate Investment Trust (SRU.UN:CA) Shareholder/Analyst Call - Slideshow (TSX:SRU.UN:CA) 2026-05-13
Seeking Alpha· 2026-05-14 07:32
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...
Accelerant Holdings (ARX) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2026-05-14 07:32
View all Key Company Metrics for Accelerant Holdings here>>> Shares of Accelerant Holdings have returned +1.4% over the past month versus the Zacks S&P 500 composite's +8.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a ...
Cytosorbents targets operating cash flow breakeven in 2H 2026 while planning DrugSorb-ATR de novo submission in late 2026/early 2027 (NASDAQ:CTSO)
Seeking Alpha· 2026-05-14 07:31
To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Bridgemarq Real Estate Services Inc. (BRE:CA) Shareholder/Analyst Call - Slideshow (TSX:BRE:CA) 2026-05-13
Seeking Alpha· 2026-05-14 07:31
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Globant S.A.
Globenewswire· 2026-05-14 07:31
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Globant S.A. and Encourages Investors with Large Losses to Contact the Firm Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Globant (GLOB) To Contact Him Directly To Discuss Their Options Click here to participate in the action. If you purchased or acquired Globant common stock between February 15, 2024 and August 14, 2025 and would like to discuss your legal rig ...
Tesla Stock Is Soaring. Is the $10 Trillion Robotaxi Story Finally a Buy?
The Motley Fool· 2026-05-14 07:31
股价近期表现 - 特斯拉股价在经历年内大部分时间下跌后,近期强劲反弹,过去一个月上涨约26%,截至撰稿时交易价格约为445美元 [1] Robotaxi业务进展 - 特斯拉的Robotaxi(自动驾驶出租车)服务是其股价近期催化剂之一,该服务被部分投资者视为一个潜在的巨大全球机会 [2] - Robotaxi服务最初于2025年中在奥斯汀推出,目前服务范围已扩展至达拉斯和休斯顿,并计划在2026年上半年拓展至凤凰城、迈阿密、奥兰多、坦帕和拉斯维加斯 [2] - 2026年第一季度,特斯拉付费Robotaxi行驶里程环比增长近一倍,表明活动正在增加 [2] - 高盛研究估计,到2035年,全球Robotaxi市场规模可能达到约4150亿美元,未来十年行业累计毛利润总额可能约为4400亿美元 [3] - 首席执行官埃隆·马斯克表示,2026年无监督全自动驾驶或Robotaxi收入可能不会非常可观,但预计在2027年将变得重要 [4] 公司财务状况与估值 - 特斯拉市值约为1.7万亿美元,基于过去12个月约980亿美元的营收和约39亿美元的净利润 [6] - 其市盈率超过400倍,市销率接近16倍 [6] - 2026年第一季度营收同比增长16%至224亿美元,但4.2%的营业利润率低于2025年第四季度的5.7% [6][7] 资本支出与现金流 - 特斯拉预计2026年资本支出将超过250亿美元,比原计划高出约50亿美元,大约是2025年86亿美元支出的三倍 [8] - 首席财务官表示,由于为多个项目提供资金,2026年剩余三个季度的自由现金流将为负 [8] - 资金投入的项目包括人工智能计算、内部AI5推理芯片、Cybercab和Megapack 3的产能提升,以及Optimus人形机器人 [9] 新业务与挑战 - Cybercab的量产刚刚开始提升,Robotaxi仍需大量运营基础设施,而Optimus人形机器人距离开始生产还有数月时间 [10] - 这些新举措均缺乏大规模运营记录,而为它们提供资金的汽车业务正以个位数利润率运营 [10]
Henry Schein, Inc. (HSIC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha· 2026-05-14 07:30
Question-and-Answer Session Before we kick off, Fred, I would love to get a sense. Do you have any prepared comments or would you love to make any comments about your first quarter as a public company CEO. CEO & Director Excellent. Thank you very much. No, it's 2 months in, and things just finished a month 2, and things are off to a good start. We had a good Q1. Really healthy growth in our dental market. Overall, growth was strong in our technology business. Growth was strong in our distribution business. ...
Travere Therapeutics, Inc. (TVTX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha· 2026-05-14 07:30
Travere Therapeutics is a commercial stage rare disease company. We've been focused on developing innovative therapies for rare kidney diseases that really have been devastating for both IgA nephropathy and FSGS communities. And we're very pleased to really pave the way for innovation and hope for these communities. We also have a Phase III program in classical homocystinuria with a pegylated enzyme replacement therapy, pegtibatinase that is now currently enrolling Phase III. President, CEO & Director Yes, ...
Priority Technology Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PRTH) 2026-05-13
Seeking Alpha· 2026-05-14 07:30
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...